{"id":601457,"date":"2026-08-31T10:00:10","date_gmt":"2026-08-31T10:00:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/601457\/"},"modified":"2026-08-31T10:00:10","modified_gmt":"2026-08-31T10:00:10","slug":"cadre-of-radiopharmaceuticals-experts-pushes-the-bounds-in-cancer-therapy","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/601457\/","title":{"rendered":"Cadre of radiopharmaceuticals experts pushes the bounds in cancer therapy"},"content":{"rendered":"<p class=\"author-bio\">Allison covers what hot startups are getting up to, and who\u2019s financing them. She is also co-host of the weekly biotech podcast, \u201c<a href=\"https:\/\/www.statnews.com\/category\/readout-loud\/\" rel=\"nofollow noopener\" target=\"_blank\">The Readout Loud<\/a>.\u201d You can reach Allison on Signal at AllisonDeAngelis.01.<\/p>\n<p class=\"wp-block-paragraph\">Louise Emmett wants radiopharmaceutical developers to be bolder.\u00a0<\/p>\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.statnews.com\/2023\/11\/08\/radiopharmaceuticals-boom-times-against-cancer\/\" rel=\"nofollow noopener\" target=\"_blank\">Radiopharmaceuticals<\/a> are a powerful new tool in oncology. She and other experts believe that these 21st-century spins on radiation could destroy cancer cells and help patients live longer. But Emmett, who is a leader in the field and works with global drugmakers including AstraZeneca and Novartis, among others, thinks the pharma industry is scared of their power. More specifically, she and likeminded experts believe the treatments can be dosed more frequently than they are.<\/p>\n<p class=\"wp-block-paragraph\">As this field has grown over the last five years, however, some drug developers have found that their experimental therapies inadvertently affect patients\u2019 kidneys, liver, or bone marrow. Such safety concerns have <a href=\"https:\/\/www.statnews.com\/2026\/08\/10\/radiopharmaceuticals-clinical-trials-progress-setbacks\/\" rel=\"nofollow noopener\" target=\"_blank\">led at least one company to shut down<\/a> in recent months and caused headaches at other organizations.\u00a0<\/p>\n<p class=\"restricted-text\">STAT+ Exclusive Story<\/p>\n<p class=\"restricted-login\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.newsbeep.com\/il\/wp-content\/uploads\/2026\/08\/stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><br \/>\n\t\t\t\t\t<\/a><\/p>\n<p>\t\t\t\tThis article is exclusive to STAT+ subscribers<br \/>\n\t\t\t\tUnlock this article \u2014 plus daily coverage and analysis of the biotech sector \u2014 by subscribing to STAT+.<\/p>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta mobile\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t\t\t\tIndividual plans<\/p>\n<p>\t\t\t\t\t\tGroup plans<\/p>\n<p>\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button view-all\" data-stat-paywall-cta=\"breaker view all plans\" aria-label=\"View All Plans\" rel=\"nofollow noopener\" target=\"_blank\">View All Plans<\/a><\/p>\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button restricted-button\" data-stat-paywall-cta=\"breaker subscribe cta 1\" rel=\"nofollow noopener\" target=\"_blank\">Subscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Allison covers what hot startups are getting up to, and who\u2019s financing them. She is also co-host of&hellip;\n","protected":false},"author":2,"featured_media":601458,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[304,114,165,85,46,7299,15830],"class_list":["post-601457","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-biotechnology","tag-business","tag-cancer","tag-il","tag-israel","tag-pharmaceuticals","tag-stat"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/601457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=601457"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/601457\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/601458"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=601457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=601457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=601457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}